Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers.

Published

Journal Article

Safety concerns and/or the stochastic nature of current transduction approaches have hampered nuclear reprogramming's clinical translation. We report a novel non-viral nanotechnology-based platform permitting deterministic large-scale transfection with single-cell resolution. The superior capabilities of our technology are demonstrated by modification of the well-established direct neuronal reprogramming paradigm using overexpression of the transcription factors Brn2, Ascl1, and Myt1l (BAM). Reprogramming efficiencies were comparable to viral methodologies (up to ~9-12%) without the constraints of capsid size and with the ability to control plasmid dosage, in addition to showing superior performance relative to existing non-viral methods. Furthermore, increased neuronal complexity could be tailored by varying BAM ratio and by including additional proneural genes to the BAM cocktail. Furthermore, high-throughput NEP allowed easy interrogation of the reprogramming process. We discovered that BAM-mediated reprogramming is regulated by AsclI dosage, the S-phase cyclin CCNA2, and that some induced neurons passed through a nestin-positive cell stage.In the field of regenerative medicine, the ability to direct cell fate by nuclear reprogramming is an important facet in terms of clinical application. In this article, the authors described their novel technique of cell reprogramming through overexpression of the transcription factors Brn2, Ascl1, and Myt1l (BAM) by in situ electroporation through nanochannels. This new technique could provide a platform for further future designs.

Full Text

Cited Authors

  • Gallego-Perez, D; Otero, JJ; Czeisler, C; Ma, J; Ortiz, C; Gygli, P; Catacutan, FP; Gokozan, HN; Cowgill, A; Sherwood, T; Ghatak, S; Malkoc, V; Zhao, X; Liao, W-C; Gnyawali, S; Wang, X; Adler, AF; Leong, K; Wulff, B; Wilgus, TA; Askwith, C; Khanna, S; Rink, C; Sen, CK; Lee, LJ

Published Date

  • February 2016

Published In

Volume / Issue

  • 12 / 2

Start / End Page

  • 399 - 409

PubMed ID

  • 26711960

Pubmed Central ID

  • 26711960

Electronic International Standard Serial Number (EISSN)

  • 1549-9642

International Standard Serial Number (ISSN)

  • 1549-9634

Digital Object Identifier (DOI)

  • 10.1016/j.nano.2015.11.015

Language

  • eng